Hims & hers introduces 6-month wegovy® new customer offer

San francisco--(business wire)--hims & hers health, inc. (nyse: hims) today announced eligible customers can access 6 months of prescription-only wegovy® at a new, affordable price, making proven obesity care and treatments more accessible, more affordable, and more connected for millions of americans. “we are always looking for long-term, sustainable ways to increase access to care for our customers,” said andrew dudum, ceo and co-founder of hims & hers. “this is another example of how.
HIMS Ratings Summary
HIMS Quant Ranking